Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 158.000 / 2.121M |
Day Range | - - - |
52 Wk Range | 4.710 - 12.430 |
Market Cap | $694.165M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 8.49% |
Days to Cover | 8.79 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aurinia Pharmaceuticals (NASDAQ: AUPH) through any online brokerage.
There are no as such competitors for Aurinia Pharmaceuticals.
The latest price target for Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by HC Wainwright & Co. on Friday, March 1, 2024. The analyst firm set a price target for 13.00 expecting AUPH to rise to within 12 months (a possible 170.83% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Aurinia Pharmaceuticals (NASDAQ: AUPH) is $4.8 last updated April 18, 2024 at 7:49 PM EDT.
There are no upcoming dividends for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Aurinia Pharmaceuticals.
Aurinia Pharmaceuticals is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.